BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26713299)

  • 1. Caralluma Fimbriata Supplementation Improves the Appetite Behavior of Children and Adolescents with Prader-Willi Syndrome.
    Griggs JL; Su XQ; Mathai ML
    N Am J Med Sci; 2015 Nov; 7(11):509-16. PubMed ID: 26713299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caralluma fimbriata extract activity involves the 5-HT2c receptor in PWS Snord116 deletion mouse model.
    Griggs JL; Mathai ML; Sinnayah P
    Brain Behav; 2018 Dec; 8(12):e01102. PubMed ID: 30353709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Case Study of Appetite Control in Prader-Willi Syndrome, Over 12-Years by the Indian Extract
    Griggs J
    Genes (Basel); 2019 Jun; 10(6):. PubMed ID: 31212875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prader-Willi syndrome: From genetics to behaviour, with special focus on appetite treatments.
    Griggs JL; Sinnayah P; Mathai ML
    Neurosci Biobehav Rev; 2015 Dec; 59():155-72. PubMed ID: 26475993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcranial direct current stimulation reduces food-craving and measures of hyperphagia behavior in participants with Prader-Willi syndrome.
    Bravo GL; Poje AB; Perissinotti I; Marcondes BF; Villamar MF; Manzardo AM; Luque L; LePage JF; Stafford D; Fregni F; Butler MG
    Am J Med Genet B Neuropsychiatr Genet; 2016 Mar; 171B(2):266-75. PubMed ID: 26590516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal oxytocin versus placebo for hyperphagia and repetitive behaviors in children with Prader-Willi Syndrome: A randomized controlled pilot trial.
    Hollander E; Levine KG; Ferretti CJ; Freeman K; Doernberg E; Desilva N; Taylor BP
    J Psychiatr Res; 2021 May; 137():643-651. PubMed ID: 33190843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial.
    Allas S; Caixàs A; Poitou C; Coupaye M; Thuilleaux D; Lorenzini F; Diene G; Crinò A; Illouz F; Grugni G; Potvin D; Bocchini S; Delale T; Abribat T; Tauber M
    PLoS One; 2018; 13(1):e0190849. PubMed ID: 29320575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxytocin in young children with Prader-Willi syndrome: Results of a randomized, double-blind, placebo-controlled, crossover trial investigating 3 months of oxytocin.
    Damen L; Grootjen LN; Juriaans AF; Donze SH; Huisman TM; Visser JA; Delhanty PJD; Hokken-Koelega ACS
    Clin Endocrinol (Oxf); 2021 May; 94(5):774-785. PubMed ID: 33296519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of Caralluma fimbriata as an appetite suppressant and weight loss supplement: a systematic review and meta-analysis of clinical trials.
    Jayawardena R; Francis TV; Abhayaratna S; Ranasinghe P
    BMC Complement Med Ther; 2021 Nov; 21(1):279. PubMed ID: 34758791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promising effects of oxytocin on social and food-related behaviour in young children with Prader-Willi syndrome: a randomized, double-blind, controlled crossover trial.
    Kuppens RJ; Donze SH; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2016 Dec; 85(6):979-987. PubMed ID: 27486141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of hyperphagia in Prader-Willi syndrome.
    Dykens EM; Maxwell MA; Pantino E; Kossler R; Roof E
    Obesity (Silver Spring); 2007 Jul; 15(7):1816-26. PubMed ID: 17636101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxytocin treatment in children with Prader-Willi syndrome: A double-blind, placebo-controlled, crossover study.
    Miller JL; Tamura R; Butler MG; Kimonis V; Sulsona C; Gold JA; Driscoll DJ
    Am J Med Genet A; 2017 May; 173(5):1243-1250. PubMed ID: 28371242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability and change over time of weight and BMI among adolescents and adults with Prader-Willi syndrome: a 6-month text-based observational study.
    Vrana-Diaz CJ; Balasubramanian P; Kayadjanian N; Bohonowych J; Strong TV
    Orphanet J Rare Dis; 2020 Sep; 15(1):233. PubMed ID: 32883323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liraglutide for Weight Management in Children and Adolescents With Prader-Willi Syndrome and Obesity.
    Diene G; Angulo M; Hale PM; Jepsen CH; Hofman PL; Hokken-Koelega A; Ramesh C; Turan S; Tauber M
    J Clin Endocrinol Metab; 2022 Dec; 108(1):4-12. PubMed ID: 36181471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of exenatide on weight and appetite in overweight adolescents and young adults with Prader-Willi syndrome.
    Salehi P; Hsu I; Azen CG; Mittelman SD; Geffner ME; Jeandron D
    Pediatr Obes; 2017 Jun; 12(3):221-228. PubMed ID: 27071367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized pilot efficacy and safety trial of diazoxide choline controlled-release in patients with Prader-Willi syndrome.
    Kimonis V; Surampalli A; Wencel M; Gold JA; Cowen NM
    PLoS One; 2019; 14(9):e0221615. PubMed ID: 31545799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial.
    Roof E; Deal CL; McCandless SE; Cowan RL; Miller JL; Hamilton JK; Roeder ER; McCormack SE; Roshan Lal TR; Abdul-Latif HD; Haqq AM; Obrynba KS; Torchen LC; Vidmar AP; Viskochil DH; Chanoine JP; Lam CKL; Pierce MJ; Williams LL; Bird LM; Butler MG; Jensen DE; Myers SE; Oatman OJ; Baskaran C; Chalmers LJ; Fu C; Alos N; McLean SD; Shah A; Whitman BY; Blumenstein BA; Leonard SF; Ernest JP; Cormier JW; Cotter SP; Ryman DC
    J Clin Endocrinol Metab; 2023 Jun; 108(7):1696-1708. PubMed ID: 36633570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.
    Gunay-Aygun M; Schwartz S; Heeger S; O'Riordan MA; Cassidy SB
    Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary Management for Adolescents with Prader-Willi Syndrome.
    Miller JL; Tan M
    Adolesc Health Med Ther; 2020; 11():113-118. PubMed ID: 32922110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.